Sandeep M. Nayak, MD

The Johns Hopkins University School of Medicine, Baltimore, Maryland

  • 5Articles
  • 42.5KReads
  • 2022–2025Active
  • 15Collaborators
  • 70Citations

About

Sandeep M. Nayak, MD, is affiliated with The Johns Hopkins University School of Medicine in Baltimore, Maryland. Nayak has published extensively on the use of psychedelics in psychotherapy, focusing on their applications in treating depression, suicidality, and related psychopharmacological interventions. The author’s work includes analyses of clinical trial methodologies and psychological support approaches within psychedelic therapy. Nayak’s research contributions appear in Psychiatrist.com from 2022 to 2025.

Publications

JCP
Psychedelic Therapies: One Drug, Multiple Treatments: Reply to Modesto-Lowe et al
Letter to the Editor

Psychedelic Therapies: One Drug, Multiple Treatments: Reply to Modesto-Lowe et al

September 1, 2025

The authors reply to a letter by Modesto-Lowe et al regarding their survey of psychedelic practitioners’ views on psychological support.
, , , et al
JCP
Psychological Support in Psychedelic Therapy
Original Research

Psychological Support in Psychedelic Therapy

February 5, 2025

The survey reveals differences of opinion among psychedelic researchers, with a slight trend toward preference for an emotive approach to psychological support.
, , , et al
JCP
Control Conditions in Randomized Trials of Psychedelics: An ACTTION Systematic Review
Systematic Review

Control Conditions in Randomized Trials of Psychedelics: An ACTTION Systematic Review

May 10, 2023

Randomized trials of psychedelics underutilize blind assessment, active drug controls, and testing psychological support against minimal-support conditions—elements that would improve quality or provide important information.
, , , et al
JCP
Corrigendum to “Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials”
Letter to the Editor

Corrigendum to “Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials”

May 9, 2022

The authors note two suicidality-related events that occurred within the studies included in their recent meta-analysis.
, , , et al
JCP
Meta-Analysis

Psychedelic Therapy and Suicidality

January 18, 2022

Psychedelic therapy shows promise for a range of mental health concerns, including suicidality. This meta-analysis is the first to systematically examine the effects of psychedelic therapy on suicidality.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe